Gak Nyangka Banget, Coba Masukkan Pisang Dan Telur Ke Dalam Tanah Dan Ini Yang Akan Terjadi
Mesothelioma
Mesothelioma is a tumor found in layers coating the lungs or chest cavity or the stomach cavity.
Mesothelioma happens predominantly in men beyond 50 years old and is every now and again connected with earlier natural or word related introduction to asbestos. It can be analyzed just by biopsy.
Patients with mesothelioma as a rule have dynamic shortness of breath because of the thickening of layers and constriction of breathing space. Liquid may aggregate in the lungs, which additionally makes breathing troublesome.
NewYork-Presbyterian/Columbia has been assigned a focal point of magnificence in the administration of mesothelioma by the National Cancer Institute of the National Institutes of Health.
Treatment frequently requires real surgery on the pleura (the covering film of the lung) and the lung and may include post-surgical chemotherapy and radiation treatment.
We are at present concentrate a few new medicines, including a novel multimodality, or blend approach, which incorporates immunization treatment, in vitro chemosensitivity testing, and medication examination, trailed by surgical evacuation and radiotherapy. A multimodality way to deal with this sickness offers patients the most obvious opportunity to be cured.
Research Studies
The multidisciplinary, interdepartmental Center for Lung Failure and the Columbia University Mesothelioma Center are looking for patients for another institutionally affirmed clinical convention to treat harmful pleural mesothelioma, an uncommon tumor that assaults the pleura, the coating layer of the lung. The Principal Investigators of this examination, to be led at both the Columbia University Medical Center and Weill Cornell grounds of NewYork-Presbyterian, are: Mark E. Ginsburg, MD, Surgical Director, Center for Lung Failure; Robert N. Taub, MD, PhD, medicinal oncologist and Director, Mesothelioma Center; Mary Louise Keohan, MD, therapeutic oncologist; and their surgical, restorative, and radiation oncology associates.
Mesothelioma patients selected in this Phase II convention will get a regimen of pre-agent chemotherapy notwithstanding post-agent chemotherapy and radiotherapy. To be considered for this investigation, patients must have histologically affirmed dangerous mesothelioma, surgically available sickness, no earlier chemotherapy or radiotherapy, and no different serous restorative or mental ailment.
For more data about this convention, or to allude a patient, please call Mary Hesdorffer, RN, Clinical Study Coordinator, Mesothelioma Center,